// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "BRENDA ALL sample BE PRIDE:0000832 material type TA dose cleavage agent details enrichment method TIP WILL mass OF ID MAJOR ancestry category data file AC SWATH PP TMT AS developmental stage disease BMC disease stage SHOULD MINOR PATO:0000461 MIAPE DJ OLS IMPLIED NCI BUT USE NCBI exclamation CF YAML MC DISCLAIMS grade PRIDE:0000834 MERCHANTABILITY ... tumor grade PATO UBERON AND patient bmi MAGE MIAME biosample accession number RFC source name NCIT:C25714 INFORMATION CV IS characteristics TAB CPTAC SP FDR FITNESS LI COLUMN IMPORTANT SAMEA PO CELL CLO NOTE SRM COULD DIA HTML II JA URL URI MS:1000484 label OPTIONAL CS RIGHTS ROW VCF NOT THAT organism part XML PRIDE:0000590 not PATCH LIMITED INITIATIVE SN THE PTM NT EFO PEPTIDESEQ WARRANTIES EW sample preparation OR HLA TO PS instrument WARRANTY RECOMMENDED EBI drug HCD PSI IDF CN III HEREIN RAW INFRINGE FAIR MHC README MONDO MAY HANCESTRO INCLUDING SILAC VK EM REQUIRED EXPRESS SHALL FOR PRIDE:0000833 MT CL PARTICULAR treatment proteomics data acquisition method MUST MS NCIT:C25683 ISA cell type SAMN individual REQUIRES FASP PMCID BTO RECOMMEND PROTEOMICS QY MS:1001251 PURPOSE smoking status PRIDE PRIDE:0000831 age ctrl LC DDA DOID spiked compound pooled sample PMID HF SDRF PRIDE:0000659 PRM biological replicate sex organism time point HUPO fraction identifier MOD file your CT ZFA ANY NCIT technical replicate ENVO STANDARDS"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "BRENDA ALL BE PRIDE:0000832 material type TA dose cleavage agent details enrichment method WILL mass OF MAJOR data file AC SWATH PP TMT AS disease BMC disease stage SHOULD MINOR PATO:0000461 MIAPE DJ OLS IMPLIED NCI BUT USE NCBI CF YAML MC DISCLAIMS grade PRIDE:0000834 MERCHANTABILITY ... tumor grade PATO UBERON AND patient bmi MAGE MIAME biosample accession number RFC NCIT:C25714 INFORMATION CV IS TAB CPTAC SP FDR FITNESS LI COLUMN SAMEA PO CELL CLO SRM COULD DIA HTML II JA URL URI MS:1000484 label OPTIONAL CS RIGHTS ROW VCF NOT THAT organism part PRIDE:0000590 PATCH LIMITED INITIATIVE SN THE PTM NT EFO PEPTIDESEQ WARRANTIES EW sample preparation OR HLA TO PS instrument WARRANTY RECOMMENDED EBI HCD PSI IDF CN III HEREIN RAW INFRINGE FAIR MHC README MONDO MAY HANCESTRO INCLUDING SILAC VK EM REQUIRED EXPRESS SHALL FOR PRIDE:0000833 MT CL PARTICULAR treatment proteomics data acquisition method MUST MS NCIT:C25683 ISA cell type SAMN individual REQUIRES FASP PMCID BTO RECOMMEND PROTEOMICS QY MS:1001251 PURPOSE smoking status PRIDE PRIDE:0000831 age LC DDA DOID spiked compound pooled sample PMID HF SDRF PRIDE:0000659 PRM biological replicate sex organism time point HUPO fraction identifier MOD CT ZFA ANY NCIT technical replicate ENVO STANDARDS"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "PATO CL UBERON:0001969 UBERON MUST UBERON:0002113 material type MAGE depletion cell type PDX ID CL:0000084 PTM EFO CL:0000815 UBERON:0000178 CL:0000236 CL:0000624 cell line MONDO:0100096 enrichment process TAB age APP developmental stage CL:0000057 UBERON:0000948 DOID UBERON:0000955 PATO:0000461 PO NOTE MONDO:0004975 SDRF CL:0000235 FACS NCBI synthetic peptide xenograft exclamation COVID organism MONDO PATO:0001421 MONDO:0004989 MONDO:0005148 UBERON:0002107 MAY CL:0000066 organism part PRIDE:0000837 disease"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "PATO CL UBERON:0001969 UBERON MUST UBERON:0002113 material type MAGE depletion cell type PDX ID CL:0000084 PTM EFO CL:0000815 UBERON:0000178 CL:0000236 CL:0000624 cell line MONDO:0100096 enrichment process TAB age APP developmental stage CL:0000057 UBERON:0000948 DOID UBERON:0000955 PATO:0000461 PO MONDO:0004975 SDRF CL:0000235 FACS NCBI synthetic peptide xenograft COVID organism MONDO PATO:0001421 MONDO:0004989 MONDO:0005148 UBERON:0002107 MAY CL:0000066 organism part PRIDE:0000837 disease"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C53554 NCIT:C4870 breast cancer subtype treatment dose CHEBI:28748 ID ER individual ancestry category menopausal status GDPR NCIT:C71732 treatment response AJCC TNM smoking status NCIT:C18206 NCIT:C15262 disease stage NCIT:C28076 IMPORTANT HANCESTRO:0009 weight body mass index SDRF NCI IV NCIT:C28078 NCIT:C27971 HANCESTRO:0005 exclamation Ann Arbor stage Dukes stage PR HIPAA pre-existing condition MONDO:0005044 MONDO TNM staging MONDO:0005148 sampling time point NCIT:C65106 NCIT:C65107 treatment status HANCESTRO CHEBI:27899 NCIT:C65108 NCIT NCIT:C27966 NCIT:C15632 compound organism part tumor grade"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C53554 NCIT:C4870 breast cancer subtype treatment dose CHEBI:28748 ID ER individual ancestry category menopausal status GDPR NCIT:C71732 treatment response AJCC TNM smoking status NCIT:C18206 NCIT:C15262 disease stage NCIT:C28076 HANCESTRO:0009 weight body mass index SDRF NCI IV NCIT:C28078 NCIT:C27971 HANCESTRO:0005 Ann Arbor stage Dukes stage PR HIPAA pre-existing condition MONDO:0005044 MONDO TNM staging MONDO:0005148 sampling time point NCIT:C65106 NCIT:C65107 treatment status HANCESTRO CHEBI:27899 NCIT:C65108 NCIT NCIT:C27966 NCIT:C15632 compound organism part tumor grade"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "CID UNIMOD:35 MS:1002631 TA cleavage agent details TIP MS:1001306 MS:1001045 UNIMOD:1 AC PRIDE:0000551 PP TMT MS:1003246 MS:1000084 modification parameters OLS MS:1001303 DTT collision energy exclamation ETD MS:1000598 MS:1000422 MS:1000443 MS1 scan range SDS MS:1002523 CV MS:1000264 alkylation reagent NOTE dissociation method DIA MS:1000484 UNIMOD label MS:1001309 PRIDE:0000561 PRIDE:0000590 CAA depletion UNIMOD:21 PRIDE:0000553 TCEP NT SH NCE RECOMMENDED UVPD HCD reduction reagent PSI MS:1001917 scan window upper limit MS:1001313 README scan window lower limit IAA SILAC REQUIRED PRIDE:0000285 MT UNIMOD:4 MS fragment mass tolerance MS:1000081 MS:1001251 PRIDE:0000564 PRIDE PAGE TOF fractionation method IAM SCX HF SDRF fraction identifier MOD MS2 mass analyzer MS:1000133 precursor mass tolerance PRIDE:0000565"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "CID UNIMOD:35 MS:1002631 TA cleavage agent details MS:1001306 MS:1001045 UNIMOD:1 AC PRIDE:0000551 PP TMT MS:1003246 MS:1000084 modification parameters OLS MS:1001303 DTT collision energy ETD MS:1000598 MS:1000422 MS:1000443 MS1 scan range SDS MS:1002523 CV MS:1000264 alkylation reagent dissociation method DIA MS:1000484 UNIMOD label MS:1001309 PRIDE:0000561 PRIDE:0000590 CAA depletion UNIMOD:21 PRIDE:0000553 TCEP NT SH NCE RECOMMENDED UVPD HCD reduction reagent PSI MS:1001917 scan window upper limit MS:1001313 scan window lower limit IAA SILAC REQUIRED PRIDE:0000285 MT UNIMOD:4 MS fragment mass tolerance MS:1000081 MS:1001251 PRIDE:0000564 PRIDE PAGE TOF fractionation method IAM SCX HF SDRF fraction identifier MOD MS2 mass analyzer MS:1000133 precursor mass tolerance PRIDE:0000565"
  }
];
